secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-RAD LABORATORIES, INC. (BIO)
CIK:        0000012208
Form:       8-K
Filed at:   2022-04-20T23:59:59+00:00
Accession:  0001193125-22-111203
Event type: debt
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Rad amends credit agreement to exclude cash over $200M from leverage ratio
------------------------------------------------------------------------------

- Amendment No. 2 redefines Leverage Ratio to deduct cash and cash equivalents exceeding $200M from total funded debt.
- Section 6.1 reporting deadlines extended: annual financials to 120 days (from 90) and quarterly to 60 days (from 45).
- Amendment effective April 15, 2022; no defaults or new borrowing; lenders include JPMorgan, Bank of America, HSBC, and others.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/12208/000119312522111203/0001193125-22-111203-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/12208/000119312522111203/d321252d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-111203

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer